Literatur
Harre U, Georgess D, Bang H, Bozec A, Axmann R, Ossipova E, Jakobsson PJ, Baum W, Nimmerjahn F, Szarka E, Sarmay G, Krumbholz G, Neumann E, Toes R, Scherer HU, Catrina AI, Klareskog L, Jurdic P, Schett G (2012) Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin. J Clin Invest 122:1791–1802
Kleyer A, Finzel S, Rech J, Manger B, Krieter M, Faustini F, Araujo E, Hueber AJ, Harre U, Engelke K, Schett G (2014) Bone loss before the clinical onset of rheumatoid arthritis in subjects with anticitrullinated protein antibodies. Ann Rheum Dis 73:854–860
Chakraborty S, Kloos B, Harre U, Schett G, Kubatzky KF (2017) Pasteurella multocida Toxin Triggers RANKL-Independent osteoclastogenesis. Front Immunol 8:185
Finzel S, Rech J, Schmidt S, Engelke K, Englbrecht M, Schett G (2013) Interleukin-6 receptor blockade induces limited repair of bone erosions in rheumatoid arthritis: a micro CT study. Ann Rheum Dis 72:396–400
Reinhardt A, Yevsa T, Worbs T, Lienenklaus S, Sandrock I, Oberdorfer L, Korn T, Weiss S, Forster R, Prinz I (2016) Interleukin-23-dependent gamma/delta T cells produce Interleukin-17 and accumulate in the enthesis, aortic valve, and ciliary body in mice. Arthritis Rheumatol 68:2476–2486
Uluckan O, Jimenez M, Karbach S, Jeschke A, Grana O, Keller J, Busse B, Croxford AL, Finzel S, Koenders M, van den Berg W, Schinke T, Amling M, Waisman A, Schett G, Wagner EF (2016) Chronic skin inflammation leads to bone loss by IL-17-mediated inhibition of Wnt signaling in osteoblasts. Sci Transl Med 8:330ra337
Scholtysek C, Katzenbeisser J, Fu H, Uderhardt S, Ipseiz N, Stoll C, Zaiss MM, Stock M, Donhauser L, Bohm C, Kleyer A, Hess A, Engelke K, David JP, Djouad F, Tuckermann JP, Desvergne B, Schett G, Kronke G (2013) PPARbeta/delta governs Wnt signaling and bone turnover. Nat Med 19:608–613
Wehmeyer C, Frank S, Beckmann D, Bottcher M, Cromme C, Konig U, Fennen M, Held A, Paruzel P, Hartmann C, Stratis A, Korb-Pap A, Kamradt T, Kramer I, van den Berg W, Kneissel M, Pap T, Dankbar B (2016) Sclerostin inhibition promotes TNF-dependent inflammatory joint destruction. Sci Transl Med 8:330ra335
Kamradt T, Drube S (2013) A complicated liaison: IL-33 and IL-33 R in arthritis pathogenesis. Arthritis Res Ther 15:115
Zaiss MM, Kurowska-Stolarska M, Bohm C, Gary R, Scholtysek C, Stolarski B, Reilly J, Kerr S, Millar NL, Kamradt T, McInnes IB, Fallon PG, David JP, Liew FY, Schett G (2011) IL-33 shifts the balance from osteoclast to alternatively activated macrophage differentiation and protects from TNF-{alpha}-mediated bone loss. J Immunol 186:6097–6105
Schulze J, Bickert T, Beil FT, Zaiss MM, Albers J, Wintges K, Streichert T, Klaetschke K, Keller J, Hissnauer TN, Spiro AS, Gessner A, Schett G, Amling M, McKenzie AN, Horst AK, Schinke T (2011) Interleukin-33 is expressed in differentiated osteoblasts and blocks osteoclast formation from bone marrow precursor cells. J Bone Miner Res 26:704–717
Dudeck A, Dudeck J, Scholten J, Petzold A, Surianarayanan S, Kohler A, Peschke K, Vohringer D, Waskow C, Krieg T, Muller W, Waisman A, Hartmann K, Gunzer M, Roers A (2011) Mast cells are key promoters of contact allergy that mediate the adjuvant effects of haptens. Immunity 34:973–984
Schubert N, Dudeck J, Liu P, Karutz A, Speier S, Maurer M, Tuckermann J, Dudeck A (2015) Mast cell promotion of T cell-driven antigen-induced arthritis despite being dispensable for antibody-induced arthritis in which T cells are bypassed. Arthritis Rheumatol 67:903–913
Kroner J, Kovtun A, Kemmler J, Messmann JJ, Strauss G, Seitz S, Schinke T, Amling M, Kotrba J, Froebel J, Dudeck J, Dudeck A, Ignatius A (2017) Mast cells are critical regulators of Bone fracture-induced inflammation and osteoclast formation and activity. J Bone Miner Res 32:2431–2444
Win SJ, Kühl AA, Sparwasser T, Hünig T, Kamradt T (2016) In vivo activation of Treg cells with a CD28 superagonist prevents and ameliorates chronic destructive arthritis in mice. Eur J Immunol 46:1193–1202
Baschant U, Frappart L, Rauchhaus U, Bruns L, Reichardt HM, Kamradt T, Brauer R, Tuckermann JP (2011) Glucocorticoid therapy of antigen-induced arthritis depends on the dimerized glucocorticoid receptor in T cells. Proc Natl Acad Sci U S A 108:19317–19322
Förderung
Die Studien sind gefördert durch die Deutsche Forschungsgemeinschaft im Rahmen des SPP1468 „Osteoimmunology – IMMUNOBONE – A Program to Unravel the Interactions between Immune System and Bone“.
Danksagung
Die Autoren danken Sandra Jeleazcov für kontinuierlich exzellente Unterstützung.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
T. Kamradt, M. Amling, B. Dankbar, A. Dudeck, M. Gunzer, A. Ignatius, G. Krönke, K. Kubatzky, T. Pap, I. Prinz, G. Schett, T. Schinke, J. Tuckermann und A. Waisman geben an, dass kein Interessenkonflikt besteht.
Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.
Rights and permissions
About this article
Cite this article
Kamradt, T., Amling, M., Dankbar, B. et al. Gegenseitige Beeinflussung von Immunsystem und Knochen. Z Rheumatol 77 (Suppl 1), 8–11 (2018). https://doi.org/10.1007/s00393-018-0454-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00393-018-0454-1